Extending the horizon in chronic heart failure - Effects of multidisciplinary, home-based intervention relative to usual care

被引:90
作者
Inglis, Sally C.
Pearson, Sue
Treen, Suzette
Gallasch, Tamara
Horowitz, John D.
Stewart, Simon
机构
[1] Baker Heart Res Inst, Melbourne, Vic 3004, Australia
[2] Univ Queensland, Fac Hlth Sci, Brisbane, Qld, Australia
[3] Univ S Australia, Div Hlth Sci, Adelaide, SA 5001, Australia
[4] Univ Adelaide, Queen Elizabeth Hosp, Dept Cardiol, Woodville, SA 5011, Australia
关键词
cost-benefit analysis; heart failure; prevention; prognosis;
D O I
10.1161/CIRCULATIONAHA.106.638122
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-The long-term impact of chronic heart failure management programs over the typical life span of affected individuals is unknown. Methods and Results-The effects of a nurse-led, multidisciplinary, home-based intervention (HBI) in a typically elderly cohort of patients with chronic heart failure initially randomized to either HBI (n=149) or usual postdischarge care (UC) (n=148) after a short-term hospitalization were studied for up to 10 years of follow-up (minimum 7.5 years of follow-up). Study end points were all-cause mortality, event-free survival (event was defined as death or unplanned hospitalization), recurrent hospital stay, and cost per life-year gained. Median survival in the HBI cohort was almost twice that of UC (40 versus 22 months; P < 0.001), with fewer deaths overall (HBI, 77% versus 89%; adjusted relative risk, 0.74; 95% CI, 0.53 to 0.80; P < 0.001). HBI was associated with prolonged event-free survival (median, 7 versus 4 months; P < 0.01). HBI patients had more unplanned readmissions (560 versus 550) but took 7 years to overtake UC; the rates of readmission (2.04 +/- 3.23 versus 3.66 +/- 7.62 admissions; P < 0.05) and related hospital stay (14.8 +/- 23.0 versus 28.4 +/- 53.4 days per patient per year; P < 0.05) were significantly lower in the HBI group. HBI was associated with 120 more life-years per 100 patients treated compared with UC (405 versus 285 years) at a cost of $1729 per additional life-year gained when we accounted for healthcare costs including the HBI. Conclusions-In altering the natural history of chronic heart failure relative to UC (via prolonged survival and reduced frequency of recurrent hospitalization), HBI is a remarkably cost- and time-effective strategy over the longer term.
引用
收藏
页码:2466 / 2473
页数:8
相关论文
共 32 条
[1]   Implantable cardioverter defibrillators and cardiac resynchronization therapy in patients with left ventricular dysfunction: Randomized trial evidence through 2004 [J].
Al-Khatib, SM ;
Sanders, GD ;
Mark, DB ;
Lee, KL ;
Bardy, GH ;
Bigger, JT ;
Buxton, AE ;
Connolly, S ;
Kadish, A ;
Moss, A ;
Feldman, AM ;
Ellenbogen, KA ;
Singh, S ;
Califf, RM .
AMERICAN HEART JOURNAL, 2005, 149 (06) :1020-1034
[2]   The process of care in preventive in-home comprehensive geriatric assessment [J].
Alessi, CA ;
Stuck, AE ;
Aronow, HU ;
Yuhas, KE ;
Bula, CJ ;
Madison, R ;
Gold, M ;
SegalGidan, F ;
Fanello, R ;
Rubenstein, LZ ;
Beck, JC .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1997, 45 (09) :1044-1050
[3]  
Bryant J, 2004, HEALTH TECHNOL ASSES, V8, P1
[4]   Age, sex, and social trends in out-of-hospital cardiac deaths in Scotland 1986-95: a retrospective cohort study [J].
Capewell, S ;
MacIntyre, K ;
Stewart, S ;
Chalmers, JWT ;
Boyd, J ;
Finlayson, A ;
Redpath, A ;
Pell, JP ;
McMurray, JJV .
LANCET, 2001, 358 (9289) :1213-1217
[5]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[6]  
Driscoll Andrea, 2006, Eur J Cardiovasc Nurs, V5, P75, DOI 10.1016/j.ejcnurse.2005.08.001
[7]   Feasibility of a nurse-monitored, outpatient-care programme for elderly patients with moderate-to-severe, chronic heart failure [J].
Ekman, I ;
Andersson, B ;
Ehnfors, M ;
Matejka, G ;
Persson, B ;
Fagerberg, B .
EUROPEAN HEART JOURNAL, 1998, 19 (08) :1254-1260
[8]   Effectiveness of home based support for older people: systematic review and meta-analysis [J].
Elkan, R ;
Kendrick, D ;
Dewey, M ;
Hewitt, M ;
Robinson, J ;
Blair, M ;
Williams, D ;
Brummell, K .
BMJ-BRITISH MEDICAL JOURNAL, 2001, 323 (7315) :719-724B
[9]   Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction:: a systematic overview of data from individual patients [J].
Flather, MD ;
Yusuf, S ;
Kober, L ;
Pfeffer, M ;
Hall, A ;
Murray, G ;
Torp-Pedersen, C ;
Ball, S ;
Pogue, J ;
Moyé, L ;
Braunwald, E .
LANCET, 2000, 355 (9215) :1575-1581
[10]   Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team - Results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) Study [J].
Gattis, WA ;
Hasselblad, V ;
Whellan, DJ ;
O'Connor, CM .
ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (16) :1939-1945